Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Winter Games
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Wegovy maker sues Hims & Hers

Digest more
Top News
Overview
Impacts
 · 9h · on MSN
Wegovy maker sues rival over 'knock-off' weight-loss drugs
Novo Nordisk says Hims & Hers' drugs breach its patent; Hims & Hers calls the lawsuit a "blatant attack".

Continue reading

 · 2d
Hims & Hers drops plan for knockoff of Novo Nordisk's new Wegovy weight loss pill
 · 1d · on MSN
Wegovy maker sues Hims & Hers after company launches $49 weight-loss pill
 · 10h
Novo Nordisk Stock Soars After Hims & Hers Scraps Copycat Weight-Loss Pill
Novo Nordisk stock surged after Hims & Hers scrapped plans to sell a copycat version of the drugmaker’s weight-loss pill following pressure from U.S. regulators.

Continue reading

 · 1d
Novo Nordisk shares rise as Hims abandons $49 weight-loss pill
 · 1d
Novo Nordisk faces more gloom from price cuts in crowded anti-obesity drugs market
KSL · 20h
Novo Nordisk sues Hims after $49 weight-loss pill sparks FDA backlash
Analysts said the lawsuit and the unusually rapid U.S. Food and Drug ⁠Administration response could mark a broader crackdown on compounded GLP-1s, potentially easing competition on the big manufacture...

Continue reading

 · 1d
Novo says it’s suing Hims to halt obesity GLP-1 drug copycats
STAT · 1d
Novo Nordisk sues Hims & Hers for infringing on a key Wegovy patent
Scientific American
4d

The next wave of GLP-1 drugs are coming—and they’re stronger than Wegovy and Zepbound

The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments. But experts wonder how much is too much
1h

GLP-1 drugs now have new guidelines

The World Health Organization has laid down its first guidelines for GLP-1 drugs like Wegovy and Zepbound. Sturla Holm Lægreid said he told his partner last week about his infidelity. The monthly mortgage payment on a $1 million home depends on your down payment, interest rate, and loan type. See what you can expect to pay each month.
AOL
1mon

After Wegovy, Zepbound Shots, This Eli Lilly Oral Pill Can Help Maintain Weight Loss

The global obesity epidemic has spurred pharmaceutical companies to invest heavily in developing effective weight management solutions, leading to a surge in clinical trials for anti-obesity medications. Amid growing demand for such treatments, significant ...
4don MSN

Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings.

There's another fight brewing around GLP-1 drugs -- this time on the delivery side.
3d

Get Zepbound for $149 With TrumpRx Coupon—Here's How to Print

After months of discussion, President Donald Trump’s new direct-to-consumer pharmaceutical site, TrumpRx, officially launched on Thursday 5. The site lists a plethora of drugs for all
6don MSN

Wegovy maker warns of 'painful' price cuts as shares plunge

Novo Nordisk is facing "unprecedented" price pressures, "intensifying competition" and patents expiring.
1don MSN

Why Eli Lilly Stock Just Popped

Novo Nordisk just did Eli Lilly stock a huge favor.
2d

A $49 Ozempic Alternative Just Launched. Novo Nordisk Says It’s ‘Illegal’ and Dangerous

Novo Nordisk threatens legal action against Hims & Hers for "duping" public with cheap compounds of its popular weight-loss drugs
  • Privacy
  • Terms